UCSF Department of Medicine Grand Rounds

Medical Grand Rounds generally takes place once a week at Parnassus, SFGH, and the VA.

An archive of previous medical grand rounds is available here.

Here is a list of upcoming medical grand rounds:

See All | Parnassus/Mt Zion | SFGH

DateDescription
Tue Aug 30

There will be no Grand Rounds 8/30/2016

SFGH: Carr Auditorium noon - 1:00 pm

Tue Sep 06

SFGH: Carr Auditorium noon - 1:00 pm

Thu Sep 08

Women's Health Year in Review

Parnassus: HSW-300 noon - 1:00 pm

Judith Walsh, MD, MPH
Professor of Medicine and Epidemiology and Biostatistics, UCSF
http://tiny.ucsf.edu/mQfRW1

*To review some of the most significant published advances in the Women’s Health medical literature over the past year and to apply this information to clinical practice
*To review and discuss new guidelines relevant to women’s health including new breast cancer screening guidelines

Dr. Walsh is a Professor of Medicine in the Division of General Internal Medicine and Department of Epidemiology and Biostatistics at UCSF. She is a primary care physician at the Women’s Health Primary Care Practice, at the UCSF Women’s Health Center of Excellence. After completing her undergraduate education at the University of California, San Diego, she received both her MD and her Master’s of Public Health degrees from the University of California, Los Angeles. She completed a residency in Internal Medicine at the University of California, San Francisco followed by a fellowship in Clinical Epidemiology at the Veterans Affairs Medical Center of San Francisco. Her research focuses on cancer screening and other preventive interventions in primary care practice. She has been funded by the American Cancer Society and the National Cancer Institute to conduct research on increasing rates of appropriate cancer screening. She often presents the “Update in Women’s Health” at the national meetings of the Society for General Internal Medicine and the American College of Physicians. She speaks frequently on women’s health issues both locally and nationally.

Tue Sep 13

Opioid Safety

SFGH: Carr Auditorium noon - 1:00 pm

Soraya Azari

Thu Sep 15

Zero to 50,000: The Story of the Hospitalist Movement and USCF’s Central Role in it

Parnassus: HSW-300 noon - 1:00 pm

Robert Wachter, MD
Professor and Interim Chairman, Department of Medicine Chief, Division of Hospital Medicine, UCSF
http://tiny.ucsf.edu/mQfRW1

*To describe the origins of the hospitalist field and UCSF's role in it
*To appreciate lessons learned from the evolution of the hospitalist field, and how they may apply to future innovations in care redesign

Robert M. Wachter, MD is Professor and Interim Chairman of the Department of Medicine at the University of California, San Francisco, where he also directs the Division of Hospital Medicine. Author of 250 articles and 6 books, he coined the term “hospitalist” in 1996 and is generally considered the “father” of the hospitalist field, the fastest growing specialty in the history of modern medicine. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine.

In the safety and quality arenas, he edits the U.S. government’s leading website on patient safety and has written two books on the subject, including Internal Bleeding and Understanding Patient Safety, the best selling safety primer. In 2004, he received the John M. Eisenberg Award, the nation’s top honor in patient safety. In 2016, Modern Healthcare magazine ranked him as the fourth most influential physician-executive in the U.S., his ninth consecutive year in the top 50 (he was #1 on the list in 2015). He has served on the healthcare advisory boards of several companies, including Google. His 2015 book, The Digital Doctor: Hope, Hype and Harm at the Dawn of Medicine’s Computer Age, was a New York Times science bestseller. He is currently chairing a group advising England’s National Health Service on its digital strategy.

Tue Sep 20

SFGH: Carr Auditorium noon - 1:00 pm

Thu Sep 22

The New Era of Opioid Safety: Cases from the Field & Tips for Frontline Providers

Parnassus: HSW-300 noon - 1:00 pm

Soraya Azari, MD
Assistant Clinical Professor of Medicine, UCSF
http://tiny.ucsf.edu/mQfRW1

*To understand the risks associated with chronic opioid therapy and be able to explain these to patients
*To be able to explain to patients about the "four quadrants" of chronic pain management and the importance of multi-modal chronic pain management
*To consider the ways we can all prescribe opioids more safely for patients

Dr. Azari is an Assistant Clinical Professor of Medicine at Zuckerberg San Franciscio General. She went to medical school at the University of Pennsylvania and completed residency in the San Francisco General Primary Care Track (or "SFPC"). Following residency, she served as Chief Resident at San Francisco General Hospital. For the last 4 years she has worked as an outpatient clinician educator at ZSFG. She is the Associate Program Director for the primary care track at ZSFG. She leads QI efforts related to safe opioid prescribing in the Richard Fine People's Clinic, and has implemented buprenorphine-naloxone prescribing in the clinic. She also works at the outpatient methadone maintenance clinic at ZSFG and has developed an HCV treatment program there. Finally, she works in the Ward 86 HIV clinic at ZSFG. She teaches primarily on the topics of substance use disorders, chronic pain, and safe opioid prescribing, and was awarded the Larry Haber and Academy of Medical Educators Awards for excellence in teaching.

Tue Sep 27

Updates in Atrial Fibrillation

SFGH: Carr Auditorium noon - 1:00 pm

Cara Pelligrini

Thu Sep 29

Engineering Human T Cell Circuitry

Parnassus: HSW-300 noon - 1:00 pm

Alexander Marson, MD, PhD
Assistant Professor, UCSF
http://tiny.ucsf.edu/mQfRW1

*Genetic variants associated with human autoimmune diseases and other complex diseases
*Recent advances in CRISPR/Cas9 as a tool for genome engineering
*Applications of Cas9 Genome Engineering for experimental editing of human immune cells, and potential for applications in cell-based therapies

Alex Marson completed medical school at Harvard, PhD training at the Whitehead Institute/MIT with Richard Young and Rudolf Jaenisch, Internal Medicine residency at the Brigham and Women’s and clinical training in Infectious Diseases at UCSF. He was a UCSF Sandler Faculty Fellow from 2013-2016. He is now an assistant professor in the UCSF Department of Microbiology and Immunology, with joint appointments in the Department of Medicine and the Diabetes Center.

Dr. Marson’s group integrates systems-scale investigations of human T cell circuitry with functional perturbation studies, including genome editing in primary T cells. His work has employed genomic techniques to study the transcriptional circuits that enable immune cells to establish highly specialized identities. He and his collaborators have systematically identified enhancers and non-coding transcripts in human immune cell subsets and developed new methodology to learn how fine-mapped genetic variants disrupt these regulatory elements to give rise to human autoimmune diseases. The Marson lab, along with collaborators at the Innovative Genomics Initiative (IGI), has developed new tools for genome engineering in primary human T cells using CRISPR/Cas9 ribonucleoproteins (RNPs). The ability to edit specific genomic sequences in human immune cells holds potential for identifying novel drug targets and for enhancing the next generation of cell-based therapies.

Tue Oct 04

SFGH: Carr Auditorium noon - 1:00 pm

Thu Oct 06

TBA

Parnassus: HSW-300 noon - 1:00 pm

Thu Oct 13

TBA

Parnassus: HSW-300 noon - 1:00 pm

 

Parnassus Statement

Accreditation

The University of California San Francisco, School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

This live activity is designated for a maximum of 1 AMA PRA Category 1 credit. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

You must sign in to qualify for CME credit.

Course Number MGR15002

*Faculty Relationship Disclosure

All speakers listed above have declared that neither they, nor any immediate member of their family, have a financial arrangement or other relationship with the manufacturers of any commercial products except *.

* All conflicts of interest have been resolved in accordance with the ACCME's Standards for Commercial Support.

Medical Grand Rounds Commercial Support Disclosure

No commercial support received for Medical Grand Rounds.

SFGH Statement

The speaker(s) declare that neither they nor any immediate family have financial or other arrangements with the manufacturers of any pharmaceutical products or medical devices discussed in this CME activity. The speaker(s) indicate that they do not intend to discuss investigational or off label use of pharmaceutical products or medical devices.

UCSF is accredited b the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians and allied health care professionals. -- CME credit is one hour.

No commercial support was received for this CME activity.